Ubs Group Ag Liva Nova PLC Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Liva Nova PLC stock. As of the latest transaction made, Ubs Group Ag holds 41,359 shares of LIVN stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,359

Previous 22,098 87.16%

Holding current value

$1.95 Million

Previous $1.21 Million 79.27%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$43.38 - $54.59 $835,542 - $1.05 Million	19,261 Added 87.16%	41,359 $2.17 Million
Q2 2024 Aug 13, 2024	SELL	$51.76 - $64.15 $2.04 Million - $2.52 Million	-39,322 Reduced 64.02%	22,098 $1.21 Million
Q1 2024 May 13, 2024	SELL	$48.6 - $57.12 $1.03 Million - $1.22 Million	-21,294 Reduced 25.74%	61,420 $3.44 Million
Q4 2023 Feb 09, 2024	BUY	$43.45 - $53.66 $901,761 - $1.11 Million	20,754 Added 33.5%	82,714 $4.28 Million
Q3 2023 Nov 09, 2023	SELL	$50.12 - $58.87 $136,877 - $160,773	-2,731 Reduced 4.22%	61,960 $3.28 Million
Q2 2023 Aug 11, 2023	SELL	$42.28 - $51.43 $83,587 - $101,677	-1,977 Reduced 2.97%	64,691 $3.33 Million
Q1 2023 May 12, 2023	BUY	$40.84 - $58.14 $946,058 - $1.35 Million	23,165 Added 53.25%	66,668 $2.91 Million
Q4 2022 Feb 08, 2023	BUY	$43.88 - $56.16 $165,734 - $212,116	3,777 Added 9.51%	43,503 $2.42 Million
Q3 2022 Nov 10, 2022	SELL	$48.37 - $66.5 $234,546 - $322,458	-4,849 Reduced 10.88%	39,726 $2.02 Million
Q2 2022 Aug 10, 2022	BUY	$57.25 - $86.63 $810,259 - $1.23 Million	14,153 Added 46.52%	44,575 $2.79 Million
Q1 2022 May 16, 2022	SELL	$71.02 - $86.99 $1.64 Million - $2 Million	-23,026 Reduced 43.08%	30,422 $2.49 Million
Q4 2021 Feb 14, 2022	BUY	$76.72 - $92.68 $2.36 Million - $2.85 Million	30,796 Added 135.95%	53,448 $4.67 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $127,561 - $148,704	1,678 Added 8.0%	22,652 $1.79 Million
Q2 2021 Aug 13, 2021	SELL	$73.44 - $87.01 $392,169 - $464,633	-5,340 Reduced 20.29%	20,974 $1.76 Million
Q1 2021 May 12, 2021	SELL	$62.9 - $82.41 $108,817 - $142,569	-1,730 Reduced 6.17%	26,314 $1.94 Million
Q4 2020 Feb 11, 2021	BUY	$46.01 - $68.74 $570,293 - $852,032	12,395 Added 79.21%	28,044 $1.86 Million
Q3 2020 Nov 12, 2020	SELL	$41.91 - $57.81 $157,874 - $217,770	-3,767 Reduced 19.4%	15,649 $707,000
Q2 2020 Jul 31, 2020	SELL	$39.87 - $56.9 $1.94 Million - $2.77 Million	-48,740 Reduced 71.51%	19,416 $935,000
Q1 2020 May 01, 2020	SELL	$34.22 - $76.49 $3.15 Million - $7.04 Million	-92,071 Reduced 57.46%	68,156 $3.08 Million
Q4 2019 Feb 14, 2020	BUY	$68.92 - $85.27 $3.69 Million - $4.56 Million	53,488 Added 50.11%	160,227 $12.1 Million
Q3 2019 Nov 14, 2019	BUY	$71.74 - $86.35 $2.12 Million - $2.56 Million	29,613 Added 38.4%	106,739 $7.88 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $1.94 Million - $2.84 Million	29,176 Added 60.85%	77,126 $5.55 Million
Q1 2019 May 14, 2019	SELL	$86.15 - $100.49 $2.45 Million - $2.85 Million	-28,398 Reduced 37.2%	47,950 $4.66 Million
Q4 2018 Feb 14, 2019	BUY	$84.14 - $125.42 $704,335 - $1.05 Million	8,371 Added 12.31%	76,348 $6.98 Million
Q3 2018 Nov 14, 2018	BUY	$101.02 - $130.95 $1.44 Million - $1.86 Million	14,227 Added 26.47%	67,977 $8.43 Million
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $3.21 Million - $4.14 Million	39,273 Added 271.28%	53,750 $5.37 Million
Q1 2018 May 15, 2018	BUY	$79.95 - $89.74 $374,405 - $420,252	4,683 Added 47.81%	14,477 $1.28 Million
Q4 2017 Feb 14, 2018	SELL	$71.8 - $88.21 $107,771 - $132,403	-1,501 Reduced 13.29%	9,794 $783,000
Q3 2017 Nov 14, 2017	BUY	$60.32 - $70.06 $277,592 - $322,416	4,602 Added 68.76%	11,295 $792,000
Q2 2017 Aug 14, 2017	SELL	N/A	-3,797 Reduced 36.2%	6,693 $409,000
Q1 2017 Nov 14, 2017	BUY	N/A	10,490	10,490 $514,000

Others Institutions Holding LIVN

# of Institutions

261

Shares Held

52.9M

Call Options Held

316K

Put Options Held

127K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.52B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account